PCN support: Think Pharmacy prospectuses relaunched

PCN support: Think Pharmacy prospectuses relaunched

June 20, 2019

As part of PSNC’s ongoing support to help LPCs and community pharmacy contractors engage with Primary Care Networks (PCNs), the PSNC Think Pharmacy prospectuses have been reviewed and updated. A number of new prospectuses have also been published to add to the range of services covered.

The prospectuses provide introductions to specific pharmacy services and they have been designed to help LPCs and others to make initial service pitches to local commissioners and stakeholders. Think Pharmacy is a brand that has been successfully used by many LPCs to engage their local commissioners to think differently about the provision of services – to ‘Think Pharmacy’ as a solution.

The Think Pharmacy prospectuses are a great way to introduce pharmacy services to commissioners; each one highlights a healthcare challenge and explains how community pharmacy can provide a solution. These may be of particular use to LPCs as they gear up their work around PCNs as well as other commissioners.

The following Think Pharmacy prospectuses are now available:

AF case finding (new) service Healthy Start vitamins service
Alcohol identification and brief advice service Hypertension case finding service
Asthma management service Inhaler technique service
Blood-borne virus screening service Minor Ailment Service via PGD
Cancer detection service Needle and syringe programme
Chlamydia screening and treatment service NHS Health Checks
Domiciliary MUR service Pharmacy reablement service
Emergency hormonal contraception service Stop smoking service
Falls prevention service Supervised consumption of medicines
Flu vaccination for children Weight management service

The prospectuses can be viewed on the Think Pharmacy page.

Word versions of the above prospectuses are also available in the LPC Members’ Area so LPCs can add their own contact details in the footer.

Posted in: , ,

More Latest News >

Wuhan Novel Coronavirus

The Medicines & Healthcare products Regulatory Agency (MHRA) has via its Central Alerting System (CAS) published an alert regarding the...